A study from the University of California, Davis, found that low levels of bad LDL cholesterol and high levels of good HDL cholesterol are linked to lower levels of amyloid plaque in the brain. Accumulation of amyloid plaque is a hallmark of Alzheimer’s disease. The research is published in the the journal JAMA Neurology.
Bruce Reed, lead study author and associate director of the UC Davis Alzheimer’s Disease Center said, “Our study shows that both higher levels of HDL — good — and lower levels of LDL — bad — cholesterol in the bloodstream are associated with lower levels of amyloid plaque deposits in the brain.”
Although the relationship between elevated cholesterol and increased risk of Alzheimer’s disease has been known for some time, the study is the first to specifically link cholesterol to amyloid deposits in living human study participants.
The researchers weren’t able to identify any associations between participant use of cholesterol medication and amyloid levels. The biological connection between blood cholesterol levels and amyloid plaque in the brain is still unclear.
Gary Chandler is a prion expert. He is the CEO of Crossbow Communications, author of several books and producer of documentaries about health and environmental issues around the world. Chandler is connecting the dots to the global surge in neurodegenerative disease, including Alzheimer’s disease, Parkinson’s disease, Creutzfeldt-Jakob disease, chronic wasting disease and other forms of prion disease. The scientific name for prion disease is transmissible spongiform encephalopathy. The operative word is “transmissible.” Even the global surge in autism appears to be related.